The Agency for Healthcare Research and Quality (AHRQ) needs a poster child like Big Bird to help it gather public support for more funding. The federal budget for the coming fiscal year (FY 2006) contains the same allocation for AHRQ as last year ($319 million), and within that, funding for AHRQ's investigator-initiated research is zero. We researchers and consumers of research findings should organize to get AHRQ more funds for this critically needed research.
For the past two years (FY 2004 and FY 2005) , the budget allocations for investigator-initiated awards (known as RO1 grants) were essentially zero. In FY 2004, AHRQ was able to pull together approximately $1 million for RO1 grants, and it hopes to fund between $1 and $2 million in such grants in FY 2005. But these monies are infinitesimal drops in the bucket compared to the $1.7 trillion spent on health care in 2003 (most recent number available) and the estimated growth rate of 8% between 2003 and 2004. Given that health care expenditures now account for more than 15% of our gross domestic product and that at least 45 million people are without health insurance, it is inconceivable that the federal budget does not contain funds for researcherinitiated projects that might address and reduce these problems.
As a nation, we need to fund projects that are proposed by researchers and judged by peer reviewers to be of high merit and likely to yield results relevant to health policies. If we do not, we risk the possibility that research will be limited to politically correct projects, according to whichever political party controls the White House, or funded by companies with their own research agenda. A process that relies on researcherinitiated projects is essential for maintaining creativity on a wide variety of topics that are within the scope of AHRQ.
AHRQ's Current Emphasis Is on Quality of Care
The budget components for AHRQ reflect a concern with ''getting good value'' for dollars spent on health care. Fair enough. We all want an efficient health care system. But how do the budget components break down? So far, $15 million has been allocated to compare the effectiveness of different medical protocols, as requested by Congress in the Medicare Modernization Act. Another $80 million is to be spent on patient safety research. Embedded in the patient safety initiative is $50 million for health information technology. (For comparison, it is worth noting that Blue Cross Blue Shield of Massachusetts announced this past spring that it is contributing $50 million this year to help fund three electronic medical record demonstration projects in Massachusetts.) Another $55 million within AHRQ's budget has been allotted to continuing the Medical Expenditures Panel Survey (MEPS) and internal research using the MEPS.
The emphasis on quality of care and value has caused a funding shift away from studies related to other topics well within AHRQ's scope of responsibility and from investigator-initiated research in particular. For example, all of AHRQ's funds for K-awards, career-development grants for promising young researchers, were shifted to health information technology course, provides an opportunity for funding relatively low-cost research that is proposed by bright young people. Without funding for the K-award and dissertation grant programs, the country may lose the potential benefits of the best members of a generation of economists, sociologists and other social scientists. They will turn their attention to non-health issues for which they can find funding.
Quality of care is an important issue if one has access to medical care-but largely irrelevant if one cannot get health insurance or otherwise pay for care. Equally important, focusing on quality of care with a strong emphasis on what ''works'' per dollar spent ignores the larger picture. Perhaps some monies shouldn't be spent regardless of their cost effectiveness. The opportunity cost of spending on some types of care might be that we are not developing cures for some diseases or conditions. Among the federal health agencies, it is the AHRQ that has the responsibility to consider larger budget issues, including the opportunity costs of various types of spending.
Moreover, while it is important to identify the factors that yield the best results in treating various conditions, we need to be careful that identifying ''best practices'' does not stifle further innovations. Perhaps changes in payment or in how medical care is delivered might yield yet higher quality of care-or the same quality at lower price. Unless attention is paid to how financing and organization affect both providers' ability to produce quality care and consumers' ability to obtain quality care, the focus on getting good value could have the unfortunate effect of locking us into current practices.
Government funding of investigator-initiated research is the only way we are likely to get innovations ''outside the box'' of current practices. A lot of companies and providers have strong selfinterests in looking for ''value'' among existing ways of providing care. They would have little interest in funding investigator-initiated research aimed at new ideas since it could alter the present share of health care dollars they receive.
Policy Issues Are in Danger of Being Ignored Without Increased Funding
A wide variety of topics is likely to be ignored by a budget that does not include funding of investigator-initiated research. One such area relates to access to health care and health insurance coverage. Major changes are occurring in employersponsored health insurance and in the ways companies hire workers-all of which are impacting who has health insurance. The MEPS can capture some of these changes, but researchers are less likely to use the MEPS data to examine the effects of the changes if AHRQ funding is not available to investigators outside the agency. Another set of issues relates to the rate at which health spending is increasing. We know the 15 most expensive diseases but we don't know why per person spending for these diseases is high. What would happen if we altered the payments to physicians and other providers so some diseases were treated differently? Right now, we pay providers for care that makes people feel better and live longer-but does such care divert attention from finding ''cures'' for diseases?
Health policy issues contain strong elements of ''collective good'' problems. It is foolish to believe that the rate of increase in health care spending or how we expand insurance coverage will be resolved by private sector initiatives alone. Moreover, researcher-initiated projects are rarely funded by private sources via a process that is peer reviewed. Foundations occasionally set up peer-review committees to determine which proposals will be funded, but the norm is to find people to do research on a topic chosen by the foundation. Private companies also fund research, but here again the companies typically have a point of view they want to push. They do not seek out researchers with ideas that are contrary to their own interests.
It is generally believed that competitive markets yield new ideas, new products, and new ways of producing goods and services at lower costs. By the same token, new ideas and insights into issues related to the financing and organization of health care have frequently come out of publicly funded, investigator-initiated research. Such research typically is related to ideas and innovations that researchers ''on the ground'' know about long before policymakers and administrators. An intriguing example is the initial research that led to AHRQ's focus on patient safety. It was done by Dr. Lucian Leape, who proposed two projects under the agency's investigatorinitiated program about 15 years ago. He received funding from then-AHCPR at a time when reducing medical errors was not even on policymakers' radar screens.
Competition for funding encourages researchers to look for variations that may yield patterns, and to think of new ways of approaching problems. This is especially pertinent in the context of AHRQ's mission, as mandated by Congress, to support research on health care costs, productivity, organization, and market forces. The need for innovative, fresh ideas on these topics has never been greater than it is now.
AHRQ is the obvious federal agency to manage the process of selecting among investigatorinitiated research proposals. It has study sections consisting of knowledgeable researchers who judge proposals on their merits. Such a process is about as fair and democratic as we are likely to see.
healthresearchfunding.org-Write!
We need to restore and increase funding for investigator-initiated research on health care financing and organization-much like public funding was increased for the Corporation for Public Broadcasting (CPB). More than a million letters and e-mails were sent to Congress urging federal funding of the CPB and public broadcasting. People clearly responded when popular programs like "Sesame Street", "All Things Considered", and "Mystery!" were threatened by funding cuts for CPB.
All of us (close to 300 million Americans) are affected by changes in health care financing and organization. The stewards of the country-the executive branch and Congress-need to know the effects of changes they implement. They cannot possibly have the time or detailed knowledge to envision analyses that might ascertain the effects of new programs or changes in financing or organizing health care.
I propose that we use ''healthresearchfunding. org'' (a Web site I created and registered) to spearhead an effort to restore funding for investigator-initiated research related to health care financing and organization. The Web site www. healthresearchfunding.org now exists to share ideas for getting Congress' attention on this matter. I have no illusions that we'll get a million e-mails and letters to Congress. But unless we make the case to Congress and the public for greater funding of research related to the financing and organization of health care, we are likely to have research that protects certain groups at the expense of others. Surely we can make the case that funding the best ideas from social scientists and researchers to make our health care system more efficient and equitable is a worthwhile investment.
